Form 4 Filing for Aura Biosciences, Inc. - Officer Stock Acquisition

This filing details a transaction by Conor Kilroy, Chief Legal Officer and Secretary of Aura Biosciences, Inc. On July 1, 2026, Kilroy acquired 14,858 shares of Common Stock through the vesting of restricted stock units (RSUs) granted under the Issuer's 2021 Stock Option and Incentive Plan. The acquisition was made at a price of $0.00 per share, indicating it was part of a stock award. Following this transaction, Kilroy holds a total of 232,693 shares. The RSUs vest in two equal annual installments starting July 15, 2027, contingent upon continued service. This event is classified as an officer transaction.